Modeling Uterine Fibroids Using Bioengineered Hydrogels
ACS Biomaterials Science & Engineering · 13.10.2025 · 11 (10) · 6068-6083
DOI: 10.1021/acsbiomaterials.5c01026 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 11.09.2025. Verfasst von Allison K Moses und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fischell Department of Bioengineering, University of Maryland, College Park, Maryland 20742, United States. Hauptthemen laut MEDLINE: Hydrogels, Leiomyoma, Uterine Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MPOWER Financing.
Abstract (Originalsprache)
Uterine fibroids are the most common gynecological tumors, characterized by excessive production of extracellular matrix. Despite their prevalence, the cellular mechanisms governing fibroid growth remain poorly understood. Current in vitro models for fibroids do not replicate the complex 3D tissue mechanics, structure, and extracellular matrix components of fibroids, which may limit our understanding of fibroid pathogenesis. To address this gap, we aimed to develop a 3D in vitro model to mimic aspects of the fibroid microenvironment. By encapsulating human uterine fibroblasts in poly(ethylene glycol) (PEG)-based hydrogels comprising collagen- and fibronectin-derived peptides, this model allows for incorporation of fibroid cellular components, extracellular matrix components, and fibroid or myometrial tissue stiffness. Due to its mechanistic role in fibroblast activation and subsequent extracellular matrix production seen in fibroids, we treated uterine fibroblasts with transforming growth factor beta 3 (TGF-β3) to demonstrate quantification of fibrotic markers observed in fibroids. Here, we establish that human uterine fibroblasts increase α smooth muscle actin, extracellular matrix proteins, and cell elongation, as well as high metabolic activity and matrix remodeling in PEG-based hydrogels in response to TGF-β3. This research represents a physiologically relevant in vitro platform to investigate uterine fibroblast function within a 3D environment that mimics uterine fibroids, with the potential to advance our understanding of the cellular and molecular mechanisms driving fibroid growth and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fischell Department of Bioengineering, University of Maryland, College Park, Maryland 20742, United States.
ORCID-Profile: Allison K Moses, Erika Moore
Förderung
- MPOWER Financing
Zitieren
APA
Moses, A. K., Tamaño-Blanco, M., & Moore, E. (2025). Modeling Uterine Fibroids Using Bioengineered Hydrogels. ACS Biomaterials Science & Engineering, 11(10), 6068-6083. https://doi.org/10.1021/acsbiomaterials.5c01026
Vancouver
Moses AK, Tamaño-Blanco M, Moore E. Modeling Uterine Fibroids Using Bioengineered Hydrogels. ACS Biomaterials Science & Engineering. 2025;11(10):6068-6083. doi:10.1021/acsbiomaterials.5c01026
BibTeX
@article{Moses2025,
author = {Moses, Allison K and Tamaño-Blanco, Miriam and Moore, Erika},
title = {Modeling Uterine Fibroids Using Bioengineered Hydrogels},
journal = {ACS Biomaterials Science & Engineering},
year = {2025},
volume = {11},
number = {10},
pages = {6068--6083},
doi = {10.1021/acsbiomaterials.5c01026}
}
EUVIMED